PHOENIX, Dec. 13, 2017 -- Solera Health today announced the appointment of healthcare industry veteran Mary Langowski as an independent director to the company’s board, effective immediately. Mary joins an existing team of experienced healthcare executives who believe Solera’s business model can positively impact healthcare costs and quality.
Founded in 2015, Solera Health has built a new market category as a preventive benefits manager connecting patients, payers, and physicians with community organizations and digital therapeutics providers delivering non-medical prevention, coping and support services. Today, Solera is successfully consolidating highly fragmented community and digital programs and services into a high-performing integrated network, allowing health plans and medical providers to increase patient engagement while lowering associated costs.
“We are thrilled to welcome Mary to our board of directors, a group which plays such a vital role in defining Solera’s roadmap for extending the reach and outcomes of our unique business model,” said Brenda Schmidt, CEO, Solera Health. “I value her rich background in identifying and expanding new market opportunities to drive growth as Solera expands and scales our capabilities to address some of our nation’s biggest health challenges.”
Mary brings deep industry experience to the Solera board which spans the private, non-profit, and public sectors. Prior to her most recent role as CEO of healthcare business consultancy Rising Tide, she served as the executive vice president for strategy and corporate development at CVS Health, where she helped facilitate the organization’s evolution to a healthcare company and managed its growth strategy, with a focus on identifying and expanding enterprise opportunities to new markets, acquisition strategies and investment initiatives. The role also involved leading the company's government and public affairs teams at the state and federal level, positioning the organization for success with policymakers and healthcare stakeholders.
Prior to CVS Health, Mary served as the chair of the Health Care practice at international law firm DLA Piper, and in senior roles in the state and federal government.
“I am excited to join Solera’s board of directors at such a pivotal time in the company’s evolution and am looking forward to working with the executive management team to broaden the influence and impact of their offering,” said Mary Langowski. “Chronic disease is changing the nature of healthcare and the needs of patients. Solera is in a unique position to transform the way we engage with these individuals in order to keep them healthy.”
About Solera Health
Solera Health is a preventive care benefits manager that connects patients, payers, and physicians with community organizations and digital therapeutics providers, simply and securely. Solera helps consolidate highly fragmented programs and services into one integrated network, allowing health plans and medical providers to increase consumer participation while lowering associated costs. Solera proactively identifies the “best fit” program provider based on each individual’s unique needs and preferences, which has proven to have a significant impact on improved patient outcomes at a fraction of the cost of traditional medical care. For more information, visit Solera Health at www.soleranetwork.com, call 800-858-1714 or follow us on Twitter @SoleraHealth or LinkedIn.
Media Contacts:
Jessy Green & Kay Kelly
SVM Public Relations
[email protected]
401.490.9700


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Samsung Electronics Shares Jump on HBM4 Mass Production Report
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Anta Sports Expands Global Footprint With Strategic Puma Stake
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



